Clinical Trial Detail

NCT ID NCT01794702
Title Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

Idarubicin

Clofarabine

Cytarabine

Decitabine

Age Groups: adult

No variant requirements are available.